ResMed Inc.

ResMed Inc. Misses on EPS, Stock Up 2.46%

ResMed's earnings report shows a slight miss on EPS, but the stock reacted positively, increasing by 2.46%. This suggests that investors may have had lower expectations or are optimistic about the company's future despite the EPS miss. Without additional context from management commentary, it's challenging to assess the long-term implications.